Tecemotide (L-BLP25) in Prostate Cancer

NCT01496131 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Radiation therapy
DRUG: Goserelin
DRUG: Cyclophosphamide
DRUG: Tecemotide (L-BLP25)

Sponsor

EMD Serono

Collaborators

[object Object]